LakeShore Biopharma Stock Target Price and Analyst Consensus
| LSB Stock | 0.73 0.09 10.98% |
Analysts of LakeShore Biopharma Co, render investment recommendations by dissecting financials, analyzing earning calls, and talking to LakeShore Biopharma vendors, executives, and customers to validate their buy-or-sell advice. Unfortunately, the analyst consensus on LakeShore Biopharma is currently unavailable. Please use our comprehensive buy-or-sell advice module to check the latest Macroaxis investment opinion on LakeShore Biopharma
As of August 3, 2025, Gross Profit is expected to decline to about 432.5 M. In addition to that, Pretax Profit Margin is expected to decline to -0.96. At present, LakeShore Biopharma's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Net Debt is expected to grow to about 215.1 M, whereas Total Assets are forecasted to decline to about 944.3 M. LakeShore | Build AI portfolio with LakeShore Stock |
It's important to approach LakeShore Biopharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize LakeShore Biopharma price targets
LakeShore Biopharma's stock target price is an estimate of its future price, usually made by analysts. Using LakeShore Biopharma's target price to determine if it is a suitable investment can be done through the following steps:- Look at LakeShore Biopharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if LakeShore Biopharma's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional LakeShore Biopharma Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of LakeShore Biopharma is a key component of LakeShore Biopharma valuation and have some predictive power on the future returns of a LakeShore Biopharma.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Target Risk ETFs Invested over 200 shares | |
| Strategy ETFs Invested over 100 shares | |
| Single Stock ETFs Invested over 100 shares | |
 | Macroaxis Index Invested over 500 shares | |
 | Real Estate Invested over 100 shares | |
Check out Macroaxis Advice on LakeShore Biopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Please note, the presentation of LakeShore Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LakeShore Biopharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of LakeShore Biopharma's management manipulating its earnings.